Vertex takes Ironwood Pharmaceuticals’ CFO Tom Graney

Vertex Pharmaceuticals Incorporated on Wednesday announced the appointment of Tom Graney as the Senior Vice President and Chief Financial Officer (CFO). 

Vertex said that Graney will start with Vertex on September 13, 2017 and will report to Executive Vice President and Chief Operating Officer Ian Smith. Furthermore, Graney will be responsible for the development and execution of the financial strategy and operations that support Vertex’s business plans, including the Finance, Accounting and Internal Audit functions. Graney most recently served as CFO and Senior Vice President of Finance and Corporate Strategy at Ironwood Pharmaceuticals.

Ian Smith, Executive Vice President and Chief Operating Officer of Vertex, said: “As Vertex continues its evolution to a leading global biotech, it is critical that we continue to build a strong and experienced leadership team. Tom has the ideal blend of financial acumen, leadership skills, and industry experience that will be important as Vertex grows and expands as a global company.”

Graney  said: “I am thrilled to take on this important role with Vertex, a company that I have long admired for its unwavering commitment to patients and to discovering, developing and commercializing transformative medicines for people with serious and life-threatening diseases.”